Skip to content
HomeLatest newsInnovationThe Johnson & Johnson Institute: 9 facts about a program that trains 125,000 healthcare providers each year
A photo of the Johnson & Johnson Institute in Irvine, California
The newest Institute location in Irvine, Calif., opened in 2017

The Johnson & Johnson Institute: 9 facts about a program that trains 125,000 healthcare providers each year

Specialty medical device training labs. An app that enables medical professionals to practice procedures via 3-D operating room simulations. Welcome to the cutting-edge Institute training program, which has 26 campuses around the world.

The newest Institute location in Irvine, Calif., opened in 2017

Where do doctors and other healthcare providers go to learn about the latest innovations and procedures in medicine?

For the past 25 years, the answer has been: the Johnson & Johnson Institute.

Since 1992, when the first Institute opened in Cincinnati, Ohio, the company has trained and educated healthcare providers—like doctors, nurses and medical students—at various Johnson & Johnson Institutes.

Today, there are 26 Institute locations across the globe, where healthcare professionals can do everything from learn how to use state-of-the-art medical device implants to watch top surgeons perform ear, nose and throat procedures.

Simply put: By providing healthcare providers with the best education possible, Johnson & Johnson is paving the way for a healthier future.

As the Institute unifies all of its operations under one umbrella this fall—the Johnson & Johnson Institute—we’re sharing some fun facts about the program’s early days and what’s in store for its future.

Visit the Institute—virtually

Check out the new Johnson & Johnson Institute website to learn more about how the company is educating healthcare providers.

Institute Infographic Final

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.